KAROLINSKA HOSPITAL STOCKHOLM, SWEDEN
Danderyd Hospital has been using CAS-One Surgery and CAS-One IR since 2014. "We have shown that precise ablation treatments are feasible and patients with non-resectable colorectal liver metastasis have improved survival outcomes when undergoing navigated microwave ablation (Engstrand et al, 2014). CAS-One IR has been used for percutaneous ablation treatments of tumors located in liver, kidney and lung. Danderyd hospital has fully integrated the CAScination systems into the clinical routine and we are satisfied with the performance, accuracy and usability of Cas-One Surgery and CAS-One IR.”
KLINIKUM BRAUNSCHWEIG, GERMANY
“At the University of Regensburg we've been using CAS-One IR navigation system since 2015. Our clinical study demonstrates that we can reduce radiation dose as well as intervention time when using CAS-One IR (Beyer et al, 2016). Our team has been evaluating several navigation and robotic guidance devices for interventional radiology and we are satisfied with performance, accuracy and usability of CAS-One IR.”
University of Innsbruck, Austria
"I have been active in the field of navigated ablation treatments for more than 15 years and know all the navigation solutions available. I am very confident that stereotactic ablation procedures will be established as standard of care in the future and that patients worldwide will benefit from focused, reliable and minimally invasive cancer treatments."